# Effect of Ascorbic Acid on Postoperative Pulmonary Complications in Patients Undergoing Cardiac Surgery

> **NCT03756727** · EARLY_PHASE1 · UNKNOWN · sponsor: **Xuzhou Medical University** · enrollment: 110 (estimated)

## Conditions studied

- Postoperative Pulmonary Complications

## Interventions

- **DRUG:** Ascorbic Acid
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT03756727
- **Lead sponsor:** Xuzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-01
- **Primary completion:** 2019-05-30
- **Final completion:** 2019-07
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2018-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03756727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03756727, "Effect of Ascorbic Acid on Postoperative Pulmonary Complications in Patients Undergoing Cardiac Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03756727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*